Managing the Complexities of Prescription Opioid Misuse and Overuse
Preventing prescription drug abuse remains a top health priority for state and federal policy makers, and one that requires a comprehensive approach. In early 2016, the Centers for Disease Control and Prevention (CDC) announced several new opioid abuse prevention and treatment initiatives and as recently as July 22, 2016 President Obama signed into law S.524, the Comprehensive Addiction Recovery Act (CARA), a framework addressing opioid abuse prevention and treatment, including evidence-based interventions. Listen as AJ Ally, Vice President of Clinical Operations at Argus Health helps you understand the new policies and implications for managing the complexities of prescription opioid abuse. The following areas will be reviewed during this discussion: 1. Drivers for opioid misuse and overuse 2. Potential impact of retail pharmacies offering free naloxone without a prescription 3. Proposed approach to managing opioid abuse and misuse through analytics and convergent solutions 4. Utilization management guidelines (FDA, CDC, CARA) & implications to health plans and manufacturers 5. Down the horizon - new and innovative treatments and solutions